SG11201405905WA - Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance - Google Patents
Beta-hydroxy-beta-methylbutyric acid for improving glucose toleranceInfo
- Publication number
- SG11201405905WA SG11201405905WA SG11201405905WA SG11201405905WA SG11201405905WA SG 11201405905W A SG11201405905W A SG 11201405905WA SG 11201405905W A SG11201405905W A SG 11201405905WA SG 11201405905W A SG11201405905W A SG 11201405905WA SG 11201405905W A SG11201405905W A SG 11201405905WA
- Authority
- SG
- Singapore
- Prior art keywords
- beta
- hydroxy
- glucose tolerance
- methylbutyric acid
- improving glucose
- Prior art date
Links
- AXFYFNCPONWUHW-UHFFFAOYSA-N 3-hydroxyisovaleric acid Chemical compound CC(C)(O)CC(O)=O AXFYFNCPONWUHW-UHFFFAOYSA-N 0.000 title 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title 1
- 239000008103 glucose Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Pediatric Medicine (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261612634P | 2012-03-19 | 2012-03-19 | |
| PCT/US2013/032831 WO2013142424A1 (en) | 2012-03-19 | 2013-03-18 | Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201405905WA true SG11201405905WA (en) | 2014-11-27 |
Family
ID=48014384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201405905WA SG11201405905WA (en) | 2012-03-19 | 2013-03-18 | Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150025143A1 (en) |
| EP (1) | EP2827850A1 (en) |
| CN (1) | CN104411305A (en) |
| CA (1) | CA2868017A1 (en) |
| HK (1) | HK1205692A1 (en) |
| IL (1) | IL234603A0 (en) |
| MX (1) | MX2014011296A (en) |
| NZ (1) | NZ630385A (en) |
| PH (1) | PH12014502071A1 (en) |
| SG (1) | SG11201405905WA (en) |
| WO (1) | WO2013142424A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013020643A2 (en) | 2011-02-17 | 2016-08-02 | Abbott Lab | methods for improving brain development and cognitive function using beta-hydroxy-beta-methylbutyrate |
| JP2015529470A (en) * | 2012-09-17 | 2015-10-08 | アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ | Composition containing β-hydroxy-β-methylbutyric acid (METHYLBUTRYICACID) and use thereof |
| EP2968236A2 (en) | 2013-03-14 | 2016-01-20 | Abbott Laboratories | Treatment of insulin resistance associated with prolonged physical inactivity |
| US11297873B2 (en) | 2016-09-13 | 2022-04-12 | Abbott Laboratories | Ketogenic nutritional compositions |
| CN111227243A (en) * | 2020-02-28 | 2020-06-05 | 昆明医科大学第一附属医院 | Food with special medical application formula |
| CA3176496A1 (en) * | 2020-04-27 | 2021-11-04 | Hana Koutnikova | Composition for reducing hepatic triglycerides and/or improving glucose metabolism |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI424840B (en) * | 2005-12-19 | 2014-02-01 | Abbott Lab | Use of β-hydroxy-β-methylbutyrate |
| JP2009155336A (en) * | 2009-03-31 | 2009-07-16 | Tsujido Chemical Corp | Treating agent |
| WO2012097064A1 (en) * | 2011-01-13 | 2012-07-19 | Abbott Laboratories | Nutritional compositions and methods for controlling blood glucose |
-
2013
- 2013-03-18 CN CN201380025906.2A patent/CN104411305A/en active Pending
- 2013-03-18 NZ NZ630385A patent/NZ630385A/en not_active IP Right Cessation
- 2013-03-18 MX MX2014011296A patent/MX2014011296A/en unknown
- 2013-03-18 US US14/386,508 patent/US20150025143A1/en not_active Abandoned
- 2013-03-18 EP EP13713057.1A patent/EP2827850A1/en not_active Withdrawn
- 2013-03-18 WO PCT/US2013/032831 patent/WO2013142424A1/en active Application Filing
- 2013-03-18 SG SG11201405905WA patent/SG11201405905WA/en unknown
- 2013-03-18 CA CA2868017A patent/CA2868017A1/en not_active Abandoned
-
2014
- 2014-09-11 IL IL234603A patent/IL234603A0/en unknown
- 2014-09-18 PH PH12014502071A patent/PH12014502071A1/en unknown
-
2015
- 2015-07-02 HK HK15106322.9A patent/HK1205692A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20150025143A1 (en) | 2015-01-22 |
| PH12014502071A1 (en) | 2014-12-10 |
| NZ630385A (en) | 2016-04-29 |
| CA2868017A1 (en) | 2013-09-26 |
| EP2827850A1 (en) | 2015-01-28 |
| CN104411305A (en) | 2015-03-11 |
| IL234603A0 (en) | 2014-11-30 |
| MX2014011296A (en) | 2014-10-17 |
| WO2013142424A1 (en) | 2013-09-26 |
| HK1205692A1 (en) | 2015-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2729182A4 (en) | Nucleic acid complex | |
| ZA201405100B (en) | Lactic acid extraction | |
| HK1214640A1 (en) | Method for connecting parts relative to one another | |
| AP4063A (en) | Dimethyl-benzoic acid compounds | |
| EP2860269A4 (en) | Method for producing sugar solution | |
| EP2860258A4 (en) | Method for producing sugar solution | |
| HK1205692A1 (en) | Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance --- | |
| SG11201504643WA (en) | Integrated process for making acetic acid | |
| EP2843061A4 (en) | Method for producing sugar solution | |
| SG11201403205SA (en) | Process for making levulinic acid | |
| EP2873730A4 (en) | Biological method for producing cis-5-hydroxy-l-pipecolinic acid | |
| EP2857528A4 (en) | Process for producing sugar solution | |
| EP2852660A4 (en) | Process | |
| EP2700414A4 (en) | Self-gelatinizable nucleic acid | |
| GB201111742D0 (en) | Solution | |
| ZA201405761B (en) | Pentose fermenting microoranisms | |
| EP2832726A4 (en) | (2-heteroarylamino)succinic acid derivative | |
| EP2712550A4 (en) | Lancet | |
| EP2682462A4 (en) | (nucleic acid)-polysaccharide complex | |
| EP2857510A4 (en) | Method for producing 3-acetylamino-4-hydroxybenzoic acid | |
| HK1193407A1 (en) | Pyrrolidine-3-ylacetic acid derivative -3- | |
| GB201107286D0 (en) | Nucleic acid preparation | |
| GB201316110D0 (en) | Phenylboronic Acid | |
| EP2799424A4 (en) | 2-fluorophenylpropionic acid derivative | |
| HK1174814A1 (en) | Lancet |